These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 7426339)

  • 81. Stabilities and characteristics of brain meninges-colonizing murine melanoma cells.
    Nicolson GL; Van Pelt C; Irimura T; Kawaguchi T
    Prog Exp Tumor Res; 1985; 29():17-35. PubMed ID: 4070630
    [No Abstract]   [Full Text] [Related]  

  • 82. Rodent models of brain metastasis in melanoma.
    Cranmer LD; Trevor KT; Bandlamuri S; Hersh EM
    Melanoma Res; 2005 Oct; 15(5):325-56. PubMed ID: 16179861
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Target organ patterns of tumors in mice following the arterial dissemination of B16 melanoma cells.
    Weiss L; Ward PM; Harlos JP; Holmes JC
    Int J Cancer; 1984 Jun; 33(6):825-30. PubMed ID: 6735524
    [TBL] [Abstract][Full Text] [Related]  

  • 84. A new allogeneic model for metastatic melanoma.
    Robinson ES; Dooley TP
    Eur J Cancer; 1995 Dec; 31A(13-14):2302-8. PubMed ID: 8652260
    [TBL] [Abstract][Full Text] [Related]  

  • 85. A murine model of intracranial invasion: morphological observations on central nervous system invasion by murine melanoma cells.
    McGrady BJ; McCormick D
    Clin Exp Metastasis; 1992 Nov; 10(6):387-93. PubMed ID: 1451348
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Liver-colonizing melanoma cells selected from B-16 melanoma.
    Tao T; Matter A; Vogel K; Burger MM
    Int J Cancer; 1979 Jun; 23(6):854-7. PubMed ID: 468414
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Repeated tandem translocations in a clone and subclones of B16-F10 murine melanoma.
    Wang RY; Hsu TC; Kendal WS
    Cancer Genet Cytogenet; 1987 Nov; 29(1):81-9. PubMed ID: 3478132
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Development and characterization of a clinically relevant mouse model of melanoma brain metastasis.
    Morsi A; Gaziel-Sovran A; Cruz-Munoz W; Kerbel RS; Golfinos JG; Hernando E; Wadghiri YZ
    Pigment Cell Melanoma Res; 2013 Sep; 26(5):743-5. PubMed ID: 23647875
    [No Abstract]   [Full Text] [Related]  

  • 89. Development of in vivo models for studies of brain metastasis.
    Schackert G; Fidler IJ
    Int J Cancer; 1988 Apr; 41(4):589-94. PubMed ID: 3356491
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Innovative Bioluminometric Quantification of Cancer Cell Load in Target Organs: Implications for Studying Anticancer Drugs, Including ROS Enhancers.
    Zhu H; Kauffman ME; Li JZ; Sarkar S; Trush MA; Jia Z; Li YR
    React Oxyg Species (Apex); 2016; 1(2):157-164. PubMed ID: 29707644
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Brain Metastasis Cell Lines Panel: A Public Resource of Organotropic Cell Lines.
    Valiente M; Van Swearingen AED; Anders CK; Bairoch A; Boire A; Bos PD; Cittelly DM; Erez N; Ferraro GB; Fukumura D; Gril B; Herlyn M; Holmen SL; Jain RK; Joyce JA; Lorger M; Massague J; Neman J; Sibson NR; Steeg PS; Thorsen F; Young LS; Varešlija D; Vultur A; Weis-Garcia F; Winkler F
    Cancer Res; 2020 Oct; 80(20):4314-4323. PubMed ID: 32641416
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Capacity for tumor cell implantation as a function of in vitro cell density.
    Bosmann HB; Lione A
    Biochem Biophys Res Commun; 1974 Nov; 61(2):564-7. PubMed ID: 4455235
    [No Abstract]   [Full Text] [Related]  

  • 93. Best Practices for Preclinical In Vivo Testing of Cancer Nanomedicines.
    Valcourt DM; Kapadia CH; Scully MA; Dang MN; Day ES
    Adv Healthc Mater; 2020 Jun; 9(12):e2000110. PubMed ID: 32367687
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Preclinical characterization of signal transducer and activator of transcription 3 small molecule inhibitors for primary and metastatic brain cancer therapy.
    Assi HH; Paran C; VanderVeen N; Savakus J; Doherty R; Petruzzella E; Hoeschele JD; Appelman H; Raptis L; Mikkelsen T; Lowenstein PR; Castro MG
    J Pharmacol Exp Ther; 2014 Jun; 349(3):458-69. PubMed ID: 24696041
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Transmigration of melanoma cells through the blood-brain barrier: role of endothelial tight junctions and melanoma-released serine proteases.
    Fazakas C; Wilhelm I; Nagyoszi P; Farkas AE; Haskó J; Molnár J; Bauer H; Bauer HC; Ayaydin F; Dung NT; Siklós L; Krizbai IA
    PLoS One; 2011; 6(6):e20758. PubMed ID: 21674054
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Characterization of brain and bone-metastasizing clones selected from an ethylnitrosourea-induced rat mammary carcinoma.
    Hall DG; Stoica G
    Clin Exp Metastasis; 1994 Jul; 12(4):283-95. PubMed ID: 8039303
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Murine models of metastatic neoplasia to the central nervous system.
    Conley FK
    Cancer Metastasis Rev; 1982; 1(3):203-13. PubMed ID: 7185422
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Spontaneously metastasizing variants derived from MNU-induced rat mammary tumour.
    Williams JC; Gusterson BA; Coombes RC
    Br J Cancer; 1982 Apr; 45(4):588-97. PubMed ID: 7073949
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Experimental systems for analysis of the malignant phenotype.
    Poste G
    Cancer Metastasis Rev; 1982; 1(2):141-99. PubMed ID: 6764376
    [TBL] [Abstract][Full Text] [Related]  

  • 100. 'Seed and soil' revisited: mechanisms of site-specific metastasis.
    Hart IR
    Cancer Metastasis Rev; 1982; 1(1):5-16. PubMed ID: 6764375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.